Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      USFDA completes inspection of J B Chemicals Panoli facility with two observations

      USFDA completes inspection of J B Chemicals Panoli facility with two observations

      Medical Dialogues Bureau15 May 2018 10:25 AM IST
      New Delhi: J B Chemicals and Pharmaceuticals said the US health regulator has completed inspection of its Panoli facility in Gujarat with two minor...
      Takeda sees lower annual profit, generics to erode cancer drug sales

      Takeda sees lower annual profit, generics to erode cancer drug sales

      Medical Dialogues Bureau15 May 2018 9:30 AM IST
      TOKYO: Japan's Takeda Pharmaceutical Co Ltd on Monday forecast a 17 percent drop in operating profit for the year through March 2019 as blood cancer...
      DoJ investigates Mylan on trade compliance for certain products

      DoJ investigates Mylan on trade compliance for certain products

      Medical Dialogues Bureau15 May 2018 9:15 AM IST
      Pharmaceuticals company Mylan NV said that one of its subsidiary received a civil investigative demand from the U.S. Department of Justice regarding...
      Artificial Intelligence facing large skills shortage: Microsoft

      Artificial Intelligence facing large skills shortage: Microsoft

      Medical Dialogues Bureau15 May 2018 9:00 AM IST
      WASHINGTON: The fast-emerging field of Artificial Intelligence, which has suddenly caught the attention of the IT industry and the governments across...
      Amazon wants Alexa to soon be your in-house doctor

      Amazon wants Alexa to soon be your in-house doctor

      Medical Dialogues Bureau14 May 2018 2:12 PM IST
      WASHINGTON: Amazon is reportedly looking at adding new abilities to its Alexa digital assistant which will allow it to potentially suggest you some...
      Aurobindo Pharmas arm recalls 2 antibiotic injections from US

      Aurobindo Pharma's arm recalls 2 antibiotic injections from US

      Medical Dialogues Bureau14 May 2018 2:12 PM IST
      Auro Medics Pharma LLC, a US subsidiary of Aurobindo Pharma Ltd,has initiated voluntary recall of two lots each of two injections from the US market...
      Chinas plans to import Indian drugs fail to enthuse Indian pharmaceutical firms

      China's plans to import Indian drugs fail to enthuse Indian pharmaceutical firms

      Medical Dialogues Bureau14 May 2018 2:11 PM IST
      China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the...
      Indian Healthcare sector may touch Rs 8.6 Trillion by FY22: Report

      Indian Healthcare sector may touch Rs 8.6 Trillion by FY22: Report

      Medical Dialogues Bureau14 May 2018 2:10 PM IST
      The healthcare industry is expected to grow annually at 16-17 percent to reach to Rs 8.6 trillion by FY22 on the back of the Centre's Ayushman Bharat...
      Fortis Healthcare shares fall nearly 3 percent

      Fortis Healthcare shares fall nearly 3 percent

      Medical Dialogues Bureau14 May 2018 2:07 PM IST
      New Delhi: Shares of Fortis Healthcare fell nearly 3 percent today after the company announced that its board has picked the offer from...
      Affordable solutions needed to intensify innovations in Indian pharma sector: DGHS

      Affordable solutions needed to intensify innovations in Indian pharma sector: DGHS

      Medical Dialogues Bureau13 May 2018 11:57 AM IST
      New Delhi: Advanced, affordable and accessible solutions is the only way forward towards intensifying the innovations in Indian pharma sector,...
      Novartis India appoints Milan Paleja as vice chairman and MD

      Novartis India appoints Milan Paleja as vice chairman and MD

      Medical Dialogues Bureau13 May 2018 9:52 AM IST
      New Delhi: Drug firm Novartis India today announced the appointment of Milan Paleja as vice chairman and managing director, with effect from June...
      Lupin, its JV submit new drug application for Etanercept biosimilar in Japan

      Lupin, its JV submit new drug application for Etanercept biosimilar in Japan

      Medical Dialogues Bureau13 May 2018 9:12 AM IST
      New Delhi: Drug firm Lupin today said its Japanese arm and YL Biologics have submitted a new drug application (NDA) with the Japanese health regulator...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok